Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03330405
Title Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Pfizer
Indications

progesterone-receptor positive breast cancer

transitional cell carcinoma

ovarian cancer

prostate cancer

estrogen-receptor positive breast cancer

Advanced Solid Tumor

lung non-small cell carcinoma

triple-receptor negative breast cancer

Therapies

Avelumab + Talazoparib

Age Groups: adult | senior
Covered Countries USA | CAN | BEL

Facility Status City State Zip Country Details
Highlands Oncology Group Fayetteville Arkansas 72703 United States Details
Highlands Oncology Group Rogers Arkansas 72758 United States Details
Highlands Oncology Group Springdale Arkansas 72762 United States Details
Tower Hematology Oncology Medical Group Beverly Hills California 90211 United States Details
Keck Hospital of USC Los Angeles California 90033 United States Details
LAC+USC Medical Center Los Angeles California 90033 United States Details
USC/Norris Comprehensive Cancer Center/Investigational Drug Services Los Angeles California 90033 United States Details
USC/Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
Cedars-Sinai Medical Center Los Angeles California 90048 United States Details
Hoag Memorial Hospital Presbyterian Newport Beach California 92663 United States Details
Freidenrich Center for Translational Research (CTRU) Palo Alto California 94304 United States Details
Stanford Cancer Institute Stanford California 94305 United States Details
Stanford Hospital and Clinics Stanford California 94305 United States Details
Stanford Women's Cancer Center Stanford California 94305 United States Details
Georgetown University Medical Center Washington District of Columbia 20007 United States Details
Massachusetts General Hospital (MGH) Boston Massachusetts 02114 United States Details
Massachusetts General Hospital Attn: Svetlana Rashkova Boston Massachusetts 02114 United States Details
Brigham & Women's Hospital Boston Massachusetts 02115 United States Details
Dana Farber Cancer Institute, Attn: Vasilika Koci, PharmD Boston Massachusetts 02215 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
University Of Minesota Health: Clinics And Surgery Center Minneapolis Minnesota 55455 United States Details
University of Minesota Medical Center, Fairview IDS Pharmacy Minneapolis Minnesota 55455 United States Details
University of Minnesota Medical Center, Fairview Minneapolis Minnesota 55455 United States Details
Roswell Park Cancer Center Institute Buffalo New York 14263 United States Details
NYU Investigational Pharmacy New York New York 10016 United States Details
NYU Langone Medical Center New York New York 10016 United States Details
NYU Laura and Isaac Perlmutter Cancer Center New York New York 10016 United States Details
Icahn School of Medicine at Mount Sinai New York New York 10029 United States Details
Mount Sinai Hospital- Pharmacy department New York New York 10029 United States Details
Cleveland Clinic Taussig Cancer Center Investigational Pharmacy Cleveland Ohio 44106 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Macquarie University North Ryde New South Wales 2109 Australia Details
Northern Cancer Institute St. Leonards New South Wales 2065 Australia Details
Mater Misericordiae Ltd Brisbane Queensland 4101 Australia Details
Fiona Stanley Hospital Murdoch Western Australia 6150 Australia Details
Institut Jules Bordet Brussels 1000 Belgium Details
Cliniques Universitaires Saint-Luc Bruxelles 1200 Belgium Details
Grand Hôpital de Charleroi - Site Notre-Dame Charleroi 6000 Belgium Details
Cross Cancer Institute Edmonton Alberta T6G 1Z2 Canada Details
Princess Margaret Cancer Centre Toronto Ontario M5G 2M9 Canada Details
Phase 1 Unit, Department of Oncology, Section 5073. Copenhagen 2100 Denmark Details
The Experimental Cancer Therapy Unit Herlev 2730 Denmark Details
Orszagos Onkologiai Intezet Budapest H-1122 Hungary Details
CRU Hungary Kft. Miskolc 3529 Hungary Details
Pecsi Tudomanyegyetem Pecs H-7624 Hungary Details
Gachon University Gil Medical Center Incheon 21565 Korea, Republic of Details
Seoul National University Hospital Seoul 03080 Korea, Republic of Details
Asan Medical Center Seoul 05505 Korea, Republic of Details
Medical Radiological Research Center n.a. A.F. Tsyba - Obninsk Kaluga Region 249036 Russian Federation Details
Medical Radiological Research Center n.a. A.F. Tsyba Obninsk Kaluga Region 249036 Russian Federation Details
GBUZ Chelyabinsk 454087 Russian Federation Details
FSBI "National Medical Research Centre of Oncology n.a. Moscow 115478 Russian Federation Details
Budget Healthcare Institution of Omsk Region "Clinical Oncology Dispensary" Omsk 644013 Russian Federation Details
State budgetary institution of healthcare of Yaroslavl region "Clinical oncology hospital" Yaroslavl 150054 Russian Federation Details
University College London Hospitals NHS Foundation Trust London Other W1T 7HA United Kingdom Details
University Hospitals of Leicester NHS Trust Leicester LE1 5WW United Kingdom Details
Freeman Hospital, The Sir Bobby Robson Cancer Trials Newcastle Upon Tyne NE7 7DN United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field